Triatomic Management LP Dexcom Inc Transaction History

Triatomic Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$86.06 - $137.93 $430,300 - $689,650	5,000 New	5,000 $466,000
Q1 2022 May 12, 2022	SELL	$94.08 - $130.2 $329,280 - $455,699	-3,500 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $454,545 - $569,870	3,500 New	3,500 $1.88 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Triatomic Management LP, based on Form 13F filings with the SEC.

Stay updated on Triatomic Management LP with notifications on news.